Cargando…
Effectiveness of Panretinal Photocoagulation Plus Intravitreal Anti-VEGF Treatment Against PRP Alone for Diabetic Retinopathy: A Systematic Review With Meta-Analysis
OBJECTIVE: To compare the efficacy and safety of panretinal photocoagulation (PRP) combined with intravitreal anti-vascular endothelial growth factor (anti-VEGF) against PRP monotherapy for diabetic retinopathy (DR). METHODS: We searched Pubmed, Cochrane Library, Web of Science, Embase, and Science...
Autores principales: | Zhang, Wuyue, Geng, Jinsong, Sang, Aimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004461/ https://www.ncbi.nlm.nih.gov/pubmed/35422768 http://dx.doi.org/10.3389/fendo.2022.807687 |
Ejemplares similares
-
Bilateral Hypertensive Retinopathy Complicated with Retinal Neovascularization: Panretinal Photocoagulation or Intravitreal Anti-VEGF Treatment?
por: Georgiadis, Odysseas, et al.
Publicado: (2014) -
A comparison between the therapeutic effects of Conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy
por: Sun, Yaoyao, et al.
Publicado: (2023) -
Longitudinal neovascular changes on optical coherence tomography angiography in proliferative diabetic retinopathy treated with panretinal photocoagulation alone versus with intravitreal conbercept plus panretinal photocoagulation: a pilot study
por: He, Feng, et al.
Publicado: (2019) -
Efficacy of intravitreal bevacizumab combined with pan retinal photocoagulation versus panretinal photocoagulation alone in treatment of proliferative diabetic retinopathy
por: Sameen, Murtaza, et al.
Publicado: (2017) -
Panretinal photocoagulation plus intravitreal conbercept for diabetic retinopathy in real world: a retrospective study
por: Wang, Xin, et al.
Publicado: (2023)